Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2014 - 2026)

Rocket Pharmaceuticals has disclosed Interest Coverage Ratio across 12 years of filings, most recently posting 102.56 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 102.56, up 24.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 114.1 (up 20.32% YoY), and the FY2025 annual result was 122.55, up 15.4% from the prior year.
• Interest Coverage Ratio came in at 102.56 for Q1 2026 at Rocket Pharmaceuticals, down from 92.95 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 91.73 in Q1 2022 to a low of 156.5 in Q2 2024.
• The 5-year median for Interest Coverage Ratio is 134.64 (2023), against an average of 129.9.
• Across the five-year window, Interest Coverage Ratio sank 304.38% in 2022 and advanced 29.88% in 2025, its largest moves.
• Rocket Pharmaceuticals' Interest Coverage Ratio stood at 147.93 in 2022, then climbed by 8.98% to 134.64 in 2023, then gained by 1.55% to 132.55 in 2024, then rose by 29.88% to 92.95 in 2025, then dropped by 10.35% to 102.56 in 2026.
• The last three Interest Coverage Ratio figures came in at 102.56 (Q1 2026), 92.95 (Q4 2025), and 110.46 (Q3 2025), per Business Quant data.